Detalhe da pesquisa
1.
RAS mutation analysis in circulating tumor DNA from patients with metastatic colorectal cancer: the AGEO RASANC prospective multicenter study.
Ann Oncol
; 29(5): 1211-1219, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29438522
2.
Molecular classification of pulmonary sarcomatoid carcinomas suggests new therapeutic opportunities.
Ann Oncol
; 28(7): 1597-1604, 2017 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28419182
3.
Clinical and molecular characteristics of non-small-cell lung cancer (NSCLC) harboring EGFR mutation: results of the nationwide French Cooperative Thoracic Intergroup (IFCT) program.
Ann Oncol
; 28(11): 2715-2724, 2017 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28945865
4.
Expression of pEGFR and pAKT as response-predictive biomarkers for RAS wild-type patients to anti-EGFR monoclonal antibodies in metastatic colorectal cancers.
Br J Cancer
; 113(4): 680-5, 2015 Aug 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-26171935
5.
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset.
Ann Oncol
; 25(12): 2378-2385, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25294886
6.
Rare EGFR exon 18 and exon 20 mutations in non-small-cell lung cancer on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT network.
Ann Oncol
; 25(1): 126-31, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24285021
7.
Expression and mutational status of treatment-relevant targets and key oncogenes in 123 malignant salivary gland tumours.
Ann Oncol
; 24(10): 2624-2629, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23933559
8.
Panitumumab combined with irinotecan for patients with KRAS wild-type metastatic colorectal cancer refractory to standard chemotherapy: a GERCOR efficacy, tolerance, and translational molecular study.
Ann Oncol
; 24(2): 412-419, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23041588
9.
[Clinical, biochemical and epidemiological features of macro-AST preceding inflammatory bowel disease diagnosis by several years]. / Caractéristiques cliniques, biochimiques et épidémiologiques d'une macro-ASAT précédant le diagnostic de maladie inflammatoire chronique de l'intestin de plusieurs années.
Rev Med Interne
; 44(5): 259-262, 2023 May.
Artigo
em Francês
| MEDLINE | ID: mdl-36958982
10.
Real-world EGFR testing practices for non-small-cell lung cancer by thoracic pathology laboratories across Europe.
ESMO Open
; 8(5): 101628, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37713929
11.
PTEN, ATM, IDH1 mutations and MAPK pathway activation as modulators of PFS and OS in patients treated by first line EGFR TKI, an ancillary study of the French Cooperative Thoracic Intergroup (IFCT) Biomarkers France project.
Lung Cancer
; 151: 69-75, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33248711
12.
Chemoradiotherapy efficacy is predicted by intra-tumour CD8+/FoxP3+ double positive T cell density in locally advanced N2 non-small-cell lung carcinoma.
Eur J Cancer
; 135: 221-229, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32610210
13.
[IHC, FISH, CISH, NGS in non-small cell lung cancer: What changes in the biomarker era?] / IHC, FISH, CISH, NGS dans les cancers bronchiques non à petites cellules : quelles évolutions dans l'ère des biomarqueurs ?
Rev Pneumol Clin
; 74(5): 327-338, 2018 Oct.
Artigo
em Francês
| MEDLINE | ID: mdl-30343945
14.
An architecture for genomics analysis in a clinical setting using Galaxy and Docker.
Gigascience
; 6(11): 1-9, 2017 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29048555
15.
Detection of plasma tumor DNA in head and neck squamous cell carcinoma by microsatellite typing and p53 mutation analysis.
Cancer Res
; 60(3): 707-11, 2000 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-10676657
16.
p53 alterations predict tumor response to neoadjuvant chemotherapy in head and neck squamous cell carcinoma: a prospective series.
J Clin Oncol
; 18(7): 1465-73, 2000 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-10735894
17.
Sequence of molecular genetic events in colorectal tumorigenesis.
Eur J Cancer Prev
; 8 Suppl 1: S39-47, 1999 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-10772417
18.
[Cellular and neoplastic otorhinolaryngologic changes, molecular markers and therapeutic potential]. / Altérations cellulaires et cancérogenèse ORL, marqueurs moléculaires et cibles thérapeutiques potentielles.
Ann Otolaryngol Chir Cervicofac
; 120(3): 152-60, 2003 Jun.
Artigo
em Francês
| MEDLINE | ID: mdl-12843984
19.
[Molecular profiling of non-small cell lung cancer]. / Biologie moléculaire et prise en charge des patients atteints d'adénocarcinomes du poumon.
Rev Pneumol Clin
; 70(1-2): 47-62, 2014.
Artigo
em Francês
| MEDLINE | ID: mdl-24566035
20.
Oncogenic mutations as predictive factors in colorectal cancer.
Oncogene
; 29(21): 3033-43, 2010 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-20383189